75 records matched your query
02876aam a2200373 a 4500 001 9698E348EC6A11E7AF65C16E97128E48 003 SILO 005 20171229012527 008 160613t20162016fluab b 001 0 eng 020 $a 1498707513 020 $a 9781498707510 035 $a (OCoLC)956622811 040 $a NLM $b eng $c NLM $d YDX $d IPL $d OCLCO $d NUI $d UtOrBLW $d SILO 042 $a nlmcopyc 050 4 $a R857.N34 060 00 $a 2016 F-962 060 10 $a QV 785 082 04 $a 615.2 $2 23 100 1 $a Chowdhury, Ezharul H. $q (Ezharul Hoque) $0 http://id.loc.gov/authorities/names/n2016187836 245 10 $a Nanotherapeutics : $b from laboratory to clinic / $c Ezharul H. Chowdhury. 264 1 $a Boca Raton : $b CRC Press, $c [2016] 300 $a xvii, 336 pages : $b color illustrations ; $c 25 cm 504 $a Includes bibliographical references and index. 505 0 $a Chapter 1. Emergence of nanotherapeutics : challenges in classical drug transport versus macromolecular drug design -- chapter 2. The ultimate destinations for delivery and release of nanotherapeutics -- chapter 3. Diversity of bioactive nanoparticles from biological, chemical, and physical perspectives -- chapter 4. Fabrication strategies for biofunctional nanoparticles -- chapter 5. Interactions and orientation of therapeutic drugs in the vicinity of nanoparticles -- chapter 6. Variable interactions of nanoparticles with blood, lymph, and extracellular and intracellular components -- chapter 7. Pharmacokinetics and biodistribution of nanoparticles -- chapter 8. Specific roles of nanoparticles in various steps of drug transport -- chapter 9. Nanotechnology approaches to modulate transport, release, and bioavailability of classical and emerging therapeutics -- chapter 10. Nanotechnology in the development of innovative treatment strategies -- chapter 11. Nanoparticles for therapeutic delivery in animal models of different cancers -- chapter 12. Nanoparticles for therapeutic delivery in animal models of other critical human diseases -- chapter 13. Nanomedicine in clinical trials -- chapter 14. Approved and commercialized nanomedicine -- chapter 15. Current safety issues : biodegradability, reactivity, and clearance. 650 12 $a Nanoparticles $x therapeutic use. $0 https://id.nlm.nih.gov/mesh/D053758Q000627 650 12 $a Drug Delivery Systems. $0 https://id.nlm.nih.gov/mesh/D016503 650 22 $a Molecular Targeted Therapy. $0 https://id.nlm.nih.gov/mesh/D058990 650 22 $a Nanomedicine. $0 https://id.nlm.nih.gov/mesh/D050997 650 0 $a Nanoparticles $x Therapeutic use. 650 0 $a Drug delivery systems. $0 http://id.loc.gov/authorities/subjects/sh88007108 650 0 $a Nanomedicine. $0 http://id.loc.gov/authorities/subjects/sh2007008651 941 $a 1 952 $l OVUX522 $d 20191211015352.0 956 $a http://locator.silo.lib.ia.us/search.cgi?index_0=id&term_0=9698E348EC6A11E7AF65C16E97128E48Initiate Another SILO Locator Search